(2003). Occupational skin-disease data in Europe. International archives of occupational and environmental health
(2004). Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Archives of dermatology
(2001). PE: Social impact of atopic dermatitis. Medicine and health,
(2002). Pharmacoeconomics of drug therapy for atopic dermatitis. Expert opinion on pharmacotherapy
(2001). Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. The British journal of dermatology
(2009). Quality of Life in chronic hand eczema as measured by the Dermatology Life Quality Index. ISPOR
(2007). Re-treatment study of alitretinoin (9-cisretinoic acid) in severe chronic hand eczema refractory to topical treatment (Poster 280). EADV
Recognized occupational diseases (1997-2006). Central Office for Statistics in Accident Insurance (SSUV).
(2008). S: Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Curr Med Res Opin
(2008). T: [New and rarley used treatment options for refractory hand eczema: local UVA-1 phototherapy, retinoids, calcineurin inhibitors]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
(2005). T: Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. The British journal of dermatology
(2003). Table 3.2.1: Occupational cases according to legal regulation
(2009). TC: Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. The British journal of dermatology
(2001). The public health approach to the burden of common skin diseases in the community. The Journal of dermatology
(1996). The role of costeffectiveness analysis in health and medicine.